X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q2 2023 Earnings Call Transcript August 10, 2023
X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.33 EPS, expectations were $-0.17.
Operator: Greetings. Welcome to X4 Pharmaceuticals’ Second Quarter 2023 Financial and Operating Results Conference Call. [Operator Instructions] As a reminder, the conference call is being recorded. It is now my pleasure to introduce your host, Dan Ferry from LifeSci Advisors. Please begin.
Dan...
